Spoken Alpha
Surgery Partners, Inc.
Surgery Partners operates a national network of ambulatory surgery centers, surgical hospitals, and physician practices across 30 states, generating approximately $3.2 billion in annual revenue from outpatient surgical procedures.
Surgery Partners, Inc is a Healthcare company operating in Medical Care Facilities with a $1.73B market cap.
SGRY beat consensus EPS by 1.0% in Q2 FY2026, reported Aug 9, 2026.
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SGRY.
$ curl https://api.spokenalpha.com/v1/companies/SGRYFAQ
Spoken Alpha indexes SGRY's earnings call transcripts at https://spokenalpha.com/companies/SGRY. Each call links to attributed speakers and parsed analyst Q&A. Surgery Partners, Inc.'s own investor relations page is at https://ir.surgerypartners.com/.
Surgery Partners, Inc. (SGRY) held its most recent earnings call on 2026-08-10, covering fiscal Q2 2026.
Surgery Partners, Inc. (SGRY) operates in the Healthcare sector (Medical Care Facilities industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-09 | $0.07 | $-0.03 | +100.0% | $848.9M | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $-0.03 | $-0.14 | +78.6% | $810.9M | — | — | EODHD |
| Q4 FY2025 | 2026-03-01 | $0.12 | $0.30 | -60.5% | $885.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $0.13 | $0.16 | -18.8% | $821.5M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $0.17 | $0.14 | +21.4% | $826.2M | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $0.04 | $0.05 | -20.0% | $776.0M | — | — | EODHD |
| Q4 FY2024 | 2025-02-23 | $0.44 | $0.38 | +16.7% | $864.4M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $0.19 | $0.26 | -26.9% | $770.4M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $0.21 | $0.20 | +5.0% | $762.1M | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $0.10 | $0.08 | +25.0% | $717.4M | — | — | EODHD |
| Q4 FY2023 | 2024-02-25 | $0.44 | $0.38 | +15.8% | $735.4M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $0.19 | $0.15 | +26.7% | $674.1M | — | — | EODHD |
| Q2 FY2023 | 2023-07-31 | $0.28 | $0.08 | +100.0% | $667.6M | — | — | EODHD |
| Q1 FY2023 | 2023-04-30 | $0.08 | $0.01 | +100.0% | $666.2M | — | — | EODHD |
| Q4 FY2022 | 2023-02-28 | $0.27 | $0.18 | +50.0% | $707.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-0.02 | $0.05 | -100.0% | $620.6M | — | — | EODHD |
| Q2 FY2022 | 2022-08-01 | $-0.03 | $-0.02 | -50.0% | $615.4M | — | — | EODHD |
| Q1 FY2022 | 2022-05-02 | $-0.09 | $-0.06 | -50.0% | $596.2M | — | — | EODHD |
| Q4 FY2021 | 2022-02-27 | $0.23 | $0.19 | +21.1% | $610.2M | — | — | EODHD |
| Q3 FY2021 | 2021-11-01 | $-0.05 | $-0.10 | +50.0% | $559.2M | — | — | EODHD |
Source: EODHD. SGRY reported actuals as published; sparse fields render as —.